Context: Obesity is a typical complex disorder resulting from behaviors promoted in westernized societies in the presence of a genetic predisposition. We hypothesized that new genes predisposing to obesity can be detected at the mRNA level. Objective: To identify susceptibility genes for obesity. Design: Linkage and expression profile data from different cohorts were combined to select novel candidate genes that were analyzed for association with obesity. Setting and participants: University Hospital in Stockholm. Adipose tissue mRNA levels were quantified in 96 women. Two large cohorts with a wide distribution in body mass index (BMI, n ¼ 1013 and 1423) were genotyped. Main outcome measure: mRNA levels and allelic association with obesity. Results: We confirmed association between candidate gene mRNA levels in adipose tissue and obesity. A total of 118 polymorphisms in 16 genes were analyzed for association with obesity. Single nucleotide polymorphism rs1064891, located in the 3 0 UTR of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) gene, was nominally associated with obesity in combined analysis of cohorts 1 and 2 (P ¼ 0.007) and, in men that were lean or had severe obesity, with BMI (P ¼ o0.005). Conclusion: To combine linkage and expression profile data is valuable in finding new obesity genes. PFKFB3, a potential regulator of glycolysis, displays decreased mRNA levels in adipose tissue of obese women, is associated with obesity and is a new promising candidate gene for obesity warranting further studies.
Introduction
Obesity is a typical complex disorder resulting from behaviors promoted in westernized societies in the presence of a genetic predisposition. 1 Although several obesity quantitative trait loci (QTLs) have been mapped by linkage analysis, identification of underlying susceptibility genes shows slow progress. 2 Recently, genome-wide association studies have identified INSIG2 and FTO as primary obesity genes. 3, 4 The association with INSIG2 has not been confirmed in all subsequent studies. [5] [6] [7] In obesity, imbalance between intake of food, regulated primarily by the brain, and energy utilization in metabolically active peripheral tissues such as adipose tissue, skeletal muscle and liver result in accumulation of fat. The literature reporting association between functional candidate genes in these organs and common obesity is immense, but has established few new obesity genes and is less likely to introduce new pathways in obesity.
Integrating gene expression profiles from relevant tissue with genetic linkages has been proposed as a novel strategy to increase the success in the difficult task of identifying genes underlying complex traits. 8 Up to now this approach, which requires gene expression profiles and genetic data from a large number of subjects, has primarily been employed in experimental models. From these studies it is clear that some expression QTLs, that is, genetic loci regulating specific gene expression, colocalize with disease QTLs supporting that differentially expressed genes are causal for disease. 8 Schadt et al. 8 have concluded that genes whose expression levels significantly correlate with a complex phenotypeFtranscript abundance are controlled by QTLs colocalizing with phenotypic QTLs, and physical locations are supported by phenotypic and expression QTLsFare natural causal candidates for disease. In humans expression mapping was performed by Cheung et al., who reported that 19% of mapped expression QTLs were cis-acting, that is, the expression QTLs map to the chromosome regions harboring the regulated genes indicating that the genes regulate their own expression. The majority of expression QTLs were regulated by one locus, which could indicate that mRNA levels display a less complex etiology and thus are easier to map than disease traits. 9, 10 Taken together, these results further support that genes, which are encoded in a disease locus and whose mRNA levels correlate with the disease, are strong candidate genes. We here report results from the, to our knowledge, first attempt to systematically combine data from human linkage analysis and gene expression profiling with the purpose of identifying susceptibility alleles for common obesity. Human adipose tissue samples can be obtained from a limited number of individuals only, making it impossible to perform genetic analysis of gene expression as a quantitative trait as described above. Rather, this study is limited to combine gene expression profiles on obese and lean women from our own laboratory 11 with published human linkage analyses of obesity in other cohorts in attempt to identify new candidate genes for obesity. Furthermore, whereas our transcriptomic approach is exploratory the selection of obesity loci from linkage analyses is by necessity hypothesis driven. No linkage analysis has been performed in the population from which the cohort used for gene expression profiling was selected. Under these circumstances, we limited our study to genetic loci reported to be linked to obesity in more than one
Caucasian population since we consider such loci most likely to be population independent and thus of greatest interest for this study. We determined which differentially expressed genes in our samples mapped to four published QTLs for obesity. Hereby identified candidate genes were analyzed for allelic association with obesity in two large independent Swedish cohorts ( Figure 1 ).
Methods

Data mining
Expression candidate genes were selected among adipose tissue expression profiles from our laboratory, since this gave us the opportunity to do follow-up studies on subjects from the same population. 11 We re-analyzed published microarray profiles on abdominal subcutaneous adipose tissue from 17 nonobese (age 36 ± 11 years, body mass index (BMI) 24±2 kg m
À2
) and 20 obese otherwise healthy (age 39±12 years, BMI 40 ± 6 kg m À2 ) Swedish women. 11 All subjects were weight stable. Of approximately 12 500 human transcripts represented on the U95A array (Affymetrix Inc., Santa Clara, CA, USA), the expression of 1000 probe sets were regulated by obesity according to significance analysis of microarrays with a false discovery rate of 5% of transcripts and fold change 430%. 12 Of these 1000 probe sets we selected those displaying a significant expression in adipose tissue, that is, were scored as present, in 41 of 3 of 37 samples according to Microarray Analysis Suite 5.0 (Affymetrix Inc.), and displaying a fold change in expression of 430% between obese and nonobese women, giving a total of 374 probe sets representing obesity-regulated transcripts in adipose tissue. The employed thresholds were in agreement with the expression differences that we previously have been able to confirm by quantitative real-time PCR (RT-qPCR). Four human obesity QTLs were selected from the literature based on the criteria (1) linkage to adult obesity or BMI in two patient cohorts including whites/Caucasians with log of the odds (LOD) score 43 or Po0.001 according to the Obesity Gene Map database (http://obesitygene.pbrc.edu), and (2) listed as confirmed obesity locus by Bell et al.,
13
( Table 1 ). The latter criteria led us to exclude chromosomes 10q21.1-10q26.3 and 13q12.11-13q14.2. For analyzed obesity QTLs, we applied the widest of the chromosome band boundaries reported for the loci in the Obesity Gene Map database. No genome scan of obesity was performed in the Swedish population from which subjects for expression profiling were selected. Since genetic linkage and expression profiles were obtained from different populations we prioritized obesity QTLs confirmed in independent populations, which are less likely to have a population-specific impact on disease.
Of 374 obesity-regulated genes in adipose tissue, 16 were located in the four selected obesity genetic loci. Obesity candidate genes, linkage and transcriptomics H Jiao et al Cohorts Cohort 1 was recruited for studying genes underlying susceptibility to obesity either from an outpatient center for treatment of obesity or through local advertisement. The subjects were carefully selected for a lean or obese phenotype, and were at least second-generation Scandinavian living in Sweden. The obese were either o21 years old with BMI 430 kg m À2 or of any age with BMI 440 kg m À2 (morbid obesity). The lean were 445 years old and had never had BMI 425 kg m À2 according to self-report. The aim of selecting subjects with extreme BMI was to enrich for a genetic impact on obesity. 13 This was also the purpose of recruiting young obese adults, since early onset of this disorder is believed to have a stronger genetic component due to reduced time of environmental impact. 13 Cohort 1 comprised obese (487 women and 124 men with age 43±13 years, BMI 45 ± 4 kg m
À2
) and lean (338 women and 64 men with age 52±6 years, BMI 22±2 kg m À2 ). A total of 59 obese subjects had oral treatment for type 2 diabetes, but otherwise the subjects in cohort 1 were healthy according to self-report.
Cohort 2, used for confirmation of genetic associations, was recruited from the same sources, but according to less stringent definitions for lean or obese phenotype than for cohort 1. The obese had BMI 430 kg m À2 at any age and the lean were 425 years old and had BMI o25 kg m
. The possibly reduced power caused by the less stringent lean and obese phenotype criteria in cohort 2 was partially overcome by a larger sample size. Cohort 2 also comprised subjects who were at least second-generation Scandinavian living in Sweden. Cohort 2 comprised obese (688 women and 122 men with age 44 ± 12 years, BMI 38 ± 5 kg m
) and lean (525 women and 88 men with age 39±7 years, BMI 22±2 kg m
). Of the obese subjects in cohort 2, 197 had hypertension, 116 had type 2 diabetes and 50 dyslipidemia, but otherwise the subjects were healthy according to self-report.
Gene-specific mRNA in abdominal subcutaneous fat was quantified in two separate cohorts due to limited availability of total RNA. Chromosome 3, 7 and 20 genes were quantified in cohort 3 comprising obese otherwise healthy (N ¼ 80, age 39±10 years, BMI 39±6 kg m ) women. In addition to the above, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) mRNA levels in abdominal subcutaneous adipose tissue were quantified in 96 women with a large interindividual variation in BMI for analysis of association with clinical and adipose tissue phenotypes related to insulin resistance (cohort 5).
All subjects were of age 18 or above and recruited independently of one another. Thus, there is no known familial relation between recruited subjects. We included both men and women in our genetic analysis since linkage analyses of obesity indicate that the majority of susceptibility alleles are common to both sexes. Our recruitment strategy for cohorts 1 and 2 resulted in a higher proportion of women. However, in both cohorts the ratios between women and men were similar among obese and lean subjects. All subjects came to the laboratory in the morning after an overnight fast. Height and weight were measured and a venous blood sample was obtained for extraction of genomic DNA. Fat biopsies were obtained as described. 23 Adipose tissue was brought to the laboratory in saline. Pieces (1-2 times, 500 mg) were immediately frozen in liquid nitrogen and kept at À70 1C.
The ethical committee of the Karolinska University Hospital approved the study. It was explained in detail to each participant and her/his consent was obtained. Cohort 2 was genotyped using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Sequenom Inc., San Diego, CA, USA) as described. 25 Primers are provided on request. Evaluation of genotyping accuracy is described in the 'Results' section. 11 Among 374 transcripts significantly up-or downregulated X30% by obesity on these arrays, the 16 genes which colocalized with the four obesity-linked genomic regions were selected for analysis in this project ( Table 2 ; Figure 1 ). To our knowledge, none of these genes have previously been investigated for impact on obesity.
Statistical analysis
Confirmation of obesity-associated gene expression in adipose tissue An independent group of age-matched obese otherwise healthy (N ¼ 80) and nonobese (N ¼ 16) women, cohort 3, was used to confirm by RT-qPCR the microarray results for the 12 obesity-regulated genes on chromosome 3, 4 and 20. We could confirm expression differences for 10 of the 12 genes (Table 2) . One exception was transmembrane 4 superfamily member 1 (TM4SF1), which on the arrays was downregulated in obesity and upregulated according to RT-qPCR analysis. We were not able to design an RT-qPCR assay for the last gene in these three loci, transcriptional coactivator with PDZ-binding motif (TAZ). Chromosome 10 genes were quantified in cohort 4 comprising age-matched obese otherwise healthy (N ¼ 22) and nonobese (N ¼ 13) women. We could confirm expression differences for three out of four genes on chromosome 10 regulated by obesity on the microarrays (Table 2) . Thus, excluding TAZ, we could confirm the microarray results for 87% (13 of 15) of genes in the four investigated genetic loci. We therefore considered the microarray data to be valid.
Characteristics of cohorts used in genetic studies
Allelic association of obesity was performed in cohort 1 comprising 611 obese and 402 lean. Nominal significant associations were confirmed in cohort 2 comprising 810 obese and 613 lean. The ascertainment criteria for cohort 1 aiming at recruiting subjects with high or no genetic predisposition to obesity, respectively, resulted in younger obese, mean age 43 years, than lean, mean age 52 years. In addition, less stringent recruitment criteria for cohort 2 resulted in phenotypic differences between cohorts 1 and 2. In cohort 2 the mean age among obese was similar to cohort 1, 44 years, whereas the lean were younger, mean age 39 years. The obese subjects in cohort 1 had a mean BMI of 45 kg m À2 and in cohort 2 a mean BMI of 38 kg m À2 . We included both men and women in our analysis since linkage analyses of obesity indicate that the majority of susceptibility alleles are common to both sexes. Cohort 1 provided 80-90% power to detect association with obesity for an allele with 20% frequency among controls, genotype relative risk 1.4 and multiplicative impact on phenotype, using a threshold P-value of 0.01-0.05 (http://pngu.mgh.harvard. edu/~purcell/cgi-bin/cc2.cgi). a Genes on chromosome 3, 7 and 20 were quantified in cohort 3. Genes on chromosome 10 were quantified in cohort 4.
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Overall genotyping strategy and results
For allelic association studies we selected in HAPMAP 150 SNPs in the regions of the 16 candidate obesity genes according to the criteria (1) SNPs defining haplotypes with frequency 45%, and (2) in regions not covered by haplotypes if available one common SNP every 5000 bp. We included potentially regulatory SNPs in 5 0 and 3 0 regions. The 150 SNPs were genotyped in cohort 1 by Illumina. A total of 32 of the genotyping assays failed (21%), which was higher than the expected 10% failure rate reported by the SNP technology platform in Uppsala (www.genotyping.se) with the applied genotyping technology. The majority of failed assays were GoldenGate validated indicating that the failure was due to interference between different SNP assays. Among the 118 successful assays, 7 SNPs were not in HWE with threshold P-value o0.05 (Supplementary Table 1 ). Five of these SNPs displayed HWE P-values 40.01, which we find satisfactory considering the large number of typed SNPs. Of remaining two SNPs, one was in HWE among controls and one displayed P-value of 0.006 among controls (Supplementary Table 1 ). The overall genotype call rate was 96.5% and the accuracy was 99.99% according to duplicate analysis of, on average, 2% of the total genotypes. On the basis of these validation experiments, we conclude that the genotyping had adequate accuracy.
Analysis of association between candidate gene alleles and obesity Three SNPs in the PFKFB3 gene, rs756567, rs1064891 and rs11257482, displayed nominal significant allelic association with obesity in cohort 1, P ¼ 0.0006-0.03 (Table 3 ). In addition, one SNP in each of TAZ, rs6440622, a-2-glycoprotein 1(AZGP1), rs2525554, MRC1, rs10242, and protective protein for b-galactosidase (PPGB), rs1736493, were nominally associated with obesity (P ¼ 0.01-0.05). We used permutations to correct the nominal P-values for multiple comparisons. The permutated P-value was 0.056 for PFKFB3 rs1064891, that is, marginally significant. No other SNP displayed a permutated significant P-value for association with obesity.
In PFKFB3 rs1064891was genotyped in cohort 2, where no significant association with obesity was observed (Table 3) . However, the trend of association was the same in cohorts 1 and 2 and the 95% confidence intervals of odds ratios from two cohorts overlapped. In addition, allelic association with pooled cohorts for rs1064891 was significant with nominal P-value 0.007 ( Table 3 ). The risk allele C showed higher frequencies among obese in both heterozygote and homozygote analyses.
Association between PFKFB3 alleles and BMI We next analyzed the impact of PFKFB3 rs1064891 on obesity phenotypes in more detail. To make cohort 2 more similar to cohort 1, which was ascertained based on more rigorous thresholds for an extreme BMI phenotype, subjects in cohort 2 with BMI 30-35 were excluded in this analysis. There was, among obese men in cohort 1 and among obese as well as lean men in cohort 2, a nominally significant difference in BMI between genotypes when including age as covariate (P ¼ o0.005; Figure 2) . In post hoc analysis there was also a nominally significant difference in BMI between CC and TT genotypes among lean men in cohort 1 (P ¼ 0.02; Figure 2 ). The TT genotype was in all analyses associated with a lower BMI compared to heterozygous. The heterozygous CT genotype did among obese men display the highest BMI. However, among obese men in cohort 2 mean BMI was one unit lower in the CC compared to the TT group. There was no difference in BMI between CC and TT genotype among obese men in cohort 1.
Analysis of candidate gene haplotypes in obesity
Haplotypes and haploblocks in the 16 obesity candidate genes inferred from genotyped SNPs are summarized in Supplementary Tables 1 and 2 . In cohort 1 seven haplotypes were nominally associated with obesity (P ¼ o0.05; Table 4 ). In permutation analysis, no haplotype remained associated with obesity. The haplotype IRF5 rs4728142, rs752637, rs7808907, rs1874328, rs2280714 alleles ACTAT with a frequency of 3.7% among cases and 1.4% among controls displayed the strongest nominal association with obesity in cohort 1 (P ¼ 0.002). Association of this haplotype with obesity could not be confirmed in cohort 2 ( Table 4) .
Analysis of PFKFB3 mRNA levels vs measures on insulin resistance PFKFB3 mRNA levels in adipose tissue were downregulated in obesity according to both the microarray and the RT-qPCR results (Table 2 ). In multiple regressions with PFKFB3 mRNA levels, BMI and age as independent variables, there was a weak inverse nominal association with serum insulin (P ¼ 0.04). By contrast, there was no association between PFKFB3 mRNA levels and plasma lipids or glucose, or HOMA-IR (results not shown), nor was there any association between PFKFB3 mRNA levels and basal or hormonestimulated lipolysis and lipogenesis (results not shown).
Discussion
Both genome-wide linkage and expression profiling provide platforms for identifying candidate genes for common obesity. However, either have its own limitations such as broad linkage peaks and uncertainty whether observed expression differences are causes or effects of obesity. In the present candidate gene association study, we combined data from linkage analyses and expression profiling. We focused on four obesity QTLs common to different populations based on the assumption that this approach would Analysis was performed separately in obese and lean. Analysis of covariance (ANCOVA) with age as covariate.
Obesity candidate genes, linkage and transcriptomics H Jiao et al reduce the impact of ethnic heterogeneity, for example, that different genes regulate obesity in the expression profiling and linkage cohorts. However, this means that our handling of gene expression profiling results was exploratory, whereas the selection of obesity genetic loci was hypothesis driven. The hypothesis underlying this study was that at least some genetic variants underlying obesity QTLs can be detected at the mRNA level. As shown by Cheung et al., a significant proportion of variation in levels of specific mRNAs maps to the chromosome regions harboring the regulated genes indicating that the genes regulate their own expression. 9, 10 Furthermore, a number of reported genes displaying allelic association with obesity such as PPARG and SREBP1C give additional support that susceptibility genes can be found among those with mRNA levels in adipose tissue associated with obesity. 29, 30 Based on the above statement we conclude that also when linkage and expression data are from different subjects genes encoded in obesity QTLs and with obesity-associated variation in mRNA levels are good candidate genes for the QTL. Among genes identified through adipose tissue expression profiling to be regulated by obesity, we selected 16 genes that were encoded in four QTLs for human obesity susceptibility. In a comprehensive allelic association analysis, SNPs in PFKFB3 and one haplotype in IRF5 were associated with obesity in cohort 1 with a nominal P-value o0.01. Though no statistically significant association with obesity was observed in a second cohort, PFKFB3 rs1064891 displayed a similar trend of association with obesity in both cohorts and for this SNP 95% confidence intervals of odds ratios from the two cohorts overlapped. Furthermore, analyses of allelic association between rs1064891 and obesity with pooled cohorts gave P-value 0.007. The weaker association between obesity and PFKFB3 in cohort 2 could be caused by phenotypic differences between cohorts, since the subjects in cohort 2 displayed less extreme lean and obese phenotypes. In subsequent analysis, excluding from analysis subjects in cohort 2 with BMI between 30 and 35 kg m
À2
, PFKFB3 rs1064891 was associated with BMI in obese and lean men in cohorts 1 and 2. The rs1064891 CC genotype protected against obesity and was associated with a lower BMI compared to heterozygous subjects.
An allele-dosage effect of PFKFB3 rs1064891 on BMI was seen in lean men only. In addition, although PFKFB3 mRNA was reduced in adipose tissue of obese women, no impact of this SNP on BMI was observed in women. These incongruous results may be caused by more then one variation in the PFKFB3 gene regulating adiposity, or could be due to chance.
PFK-2/FBPase catalyzes the synthesis and degradation of fructose 2,6-bisphosphate (F2,6BP), which is a powerful activator of phosphofructokinase, the rate-limiting enzyme of glycolysis. The platelet phosphofructokinase gene displays strong association with obesity in a recent genome-wide association study. 31 Four genes encoding PFK-2/FBPase (PFKFB1-4) have been found to mediate F2,6BP production. PFKFB3 mRNA and protein has been shown to be significantly increased during adipocyte differentiation and PFKFB3 has been proposed to be responsible for the activation of glycolysis in adipocytes. 32 Taking together, the function ascribed to PFKFB3 in adipocytes, observed downregulated mRNA levels in adipose tissue of obese subjects and allelic association results make the PFKFB3 gene a candidate gene for obesity warranting further studies. The rs1064891 SNP is encoded in the 3 0 untranslated region of PFKFB3 and could hypothetically regulate mRNA levels. There is no nonsynonymous SNP in PFKFB3 in the databases.
We observed no association between PFKFB3 mRNA levels in subcutaneous adipose tissue and clinical measures of insulin resistance, and adipocyte lipolysis or lipogenesis. Thus, the molecular metabolic consequences of reduced PFKFB3 in adipocytes as observed in obese women are unknown. Furthermore, there is no evidence that PFKFB3 mRNA levels have an impact on metabolic complications of obesity such as insulin resistance and dyslipidemia. Obesity candidate genes, linkage and transcriptomics H Jiao et al One problem in searching for genes underlying susceptibility to complex traits is that individual QTLs are expected to have minor impact on disease and the phenotypic variance attributed to specific loci to be modest. This refers not only to clinical disease, but also to disease-related phenotypes such as mRNA levels that are cis-regulated by the QTLs. In our study we were able to confirm differences by RT-qPCR in mRNA levels of 430% between obese and nonobese women. Moreover, approximately 30% difference in mRNA levels between genotypes have been easily detectable for the type 1 diabetes and multiple sclerosis susceptibility genes CTLA4 and MHC2TA, supporting that disease-predisposing alleles can be detected at the mRNA level. 33, 34 If differences in that order can be detected between genotypes, we consider similar differences in mRNA levels between cases and controls to be relevant and our threshold for selecting obesity candidate genes appropriate. In summary, in this first attempt to employ the proposed strategy of integrating data from linkage analysis with gene expression profiles to identify alleles underlying susceptibility to human obesity, one potential obesity candidate gene, PFKFB3, was identified that is proposed for further study. Though with low yield of association we show the feasibility of the approach of finding allelic association based on expression profiling aided by genetic mapping information.
